Data as of Jan 30
| -0.0301 / -3.63%|
The 3 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 5.00, with a high estimate of 5.50 and a low estimate of 3.00. The median estimate represents a +525.00% increase from the last price of 0.80.
The current consensus among 3 polled investment analysts is to Buy stock in InspireMD Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.